Changxuan You

5.3k total citations
33 papers, 496 citations indexed

About

Changxuan You is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Changxuan You has authored 33 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Oncology and 9 papers in Immunology. Recurrent topics in Changxuan You's work include Immunotherapy and Immune Responses (8 papers), Virus-based gene therapy research (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Changxuan You is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Virus-based gene therapy research (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Changxuan You collaborates with scholars based in China, United States and Italy. Changxuan You's co-authors include Rongcheng Luo, Rong Li, Jianpeng Chen, Yi Luan, Xiaohua Chen, Yuan He, Paul L. Hermonat, Tao Sun, Zhiyong Yang and Gui‐Qi Zhu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Changxuan You

30 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changxuan You China 13 240 139 127 81 77 33 496
Kalpit Shah United States 10 289 1.2× 59 0.4× 91 0.7× 75 0.9× 34 0.4× 19 507
Jagmohan Hooda United States 12 299 1.2× 60 0.4× 32 0.3× 107 1.3× 21 0.3× 22 502
Roseline Guibon France 12 198 0.8× 42 0.3× 88 0.7× 88 1.1× 31 0.4× 20 428
Basma Guarmit France 10 223 0.9× 34 0.2× 46 0.4× 62 0.8× 22 0.3× 19 473
Shangyi Fu United States 14 367 1.5× 78 0.6× 40 0.3× 143 1.8× 37 0.5× 32 672
Thomas Strub France 11 528 2.2× 128 0.9× 19 0.1× 81 1.0× 101 1.3× 17 781
Christopher J. Winters United States 15 350 1.5× 23 0.2× 118 0.9× 31 0.4× 56 0.7× 26 528
Kenichi Iwai Japan 12 217 0.9× 71 0.5× 25 0.2× 35 0.4× 53 0.7× 29 446
Shahzad Bhatti Pakistan 12 224 0.9× 74 0.5× 23 0.2× 67 0.8× 32 0.4× 43 439
Aixia Ren United States 13 288 1.2× 79 0.6× 101 0.8× 36 0.4× 24 0.3× 22 481

Countries citing papers authored by Changxuan You

Since Specialization
Citations

This map shows the geographic impact of Changxuan You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changxuan You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changxuan You more than expected).

Fields of papers citing papers by Changxuan You

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changxuan You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changxuan You. The network helps show where Changxuan You may publish in the future.

Co-authorship network of co-authors of Changxuan You

This figure shows the co-authorship network connecting the top 25 collaborators of Changxuan You. A scholar is included among the top collaborators of Changxuan You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changxuan You. Changxuan You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
You, Changxuan, Ping Ye, Li Zhang, et al.. (2025). LncRNA 4933431K23Rik modulate microglial phenotype via inhibiting miR-10a-5p in spinal cord injury induced neuropathic pain. Scientific Reports. 15(1). 11620–11620. 2 indexed citations
3.
Zheng, Zong‐Ping, Desheng Liang, Yongjin Zhang, et al.. (2025). SERUM LncRNA SNHG16: A Biomarker for Diagnosing Childhood Obesity and Predicting Its Progression to Metabolic Syndrome. Diabetes Metabolic Syndrome and Obesity. Volume 18. 2305–2316.
4.
Li, Chunxi, et al.. (2024). Comparison of the upper and lower airway microbiome in early postoperative lung transplant recipients. Microbiology Spectrum. 12(6). e0379123–e0379123. 1 indexed citations
5.
Lv, Meng, Xuanyu He, Yating Zheng, et al.. (2022). Homologous recombination repair gene mutations as a predictive biomarker for immunotherapy in patients with advanced melanoma. Frontiers in Immunology. 13. 871756–871756. 6 indexed citations
6.
He, Yuan, et al.. (2020). Sleep quality, anxiety and depression in advanced lung cancer: patients and caregivers. BMJ Supportive & Palliative Care. 12(e2). e194–e200. 40 indexed citations
7.
He, Yuan, Tao Tang, Ling Deng, et al.. (2019). Prognostic Implications of Tripartite Motif Containing 24 Expression Levels in Patients with Solid Tumors: A Systematic Review and Meta-Analysis. Genetic Testing and Molecular Biomarkers. 23(7). 473–479. 3 indexed citations
8.
You, Changxuan, Yang Yu, & Beili Gao. (2018). Imperatorin Targets MCL-1 to Sensitize CD133+ Lung Cancer Cells to γδ-T Cell-Mediated Cytotoxicity. Cellular Physiology and Biochemistry. 49(1). 235–244. 7 indexed citations
9.
You, Changxuan, et al.. (2018). Expression of miR‑21 and miR‑138 in colon cancer and its effect on cell proliferation and prognosis. Oncology Letters. 17(2). 2271–2277. 34 indexed citations
10.
He, Yuan, et al.. (2015). Role of Aurora-A in Ovarian Cancer: A Meta-Analysis. Oncology Research and Treatment. 38(9). 442–447. 3 indexed citations
11.
He, Yuan, Zhiyong Yang, Tao Sun, et al.. (2015). CCNB2 overexpression is a poor prognostic biomarker in Chinese NSCLC patients. Biomedicine & Pharmacotherapy. 74. 222–227. 86 indexed citations
12.
You, Changxuan, et al.. (2014). [Development of a lung cancer vaccine by transfecting dendritic cells with rAAV/CEA].. PubMed. 34(4). 487–91. 2 indexed citations
13.
Rong, Xiaoxiang, Xiaoli Cai, Rong Li, et al.. (2014). Positron emission tomography‐computed tomography on predicting the efficacy of targeted therapy for lung adenocarcinoma. Thoracic Cancer. 5(4). 297–303. 5 indexed citations
14.
Hu, Xingsheng, Baohui Han, Aiqin Gu, et al.. (2014). A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC). Lung Cancer. 86(2). 207–212. 31 indexed citations
15.
Wang, Xiaoqing, et al.. (2012). Antiproliferative potential of Artemisia capillaris polysaccharide against human nasopharyngeal carcinoma cells. Carbohydrate Polymers. 92(2). 1040–1045. 22 indexed citations
16.
You, Changxuan, et al.. (2012). AAV2/IL-12 gene delivery into dendritic cells (DC) enhances CTL stimulation above other IL-12 applications. OncoImmunology. 1(6). 847–855. 13 indexed citations
17.
Chen, Jianpeng, Yi Luan, Changxuan You, et al.. (2010). TRPM7 regulates the migration of human nasopharyngeal carcinoma cell by mediating Ca2+ influx. Cell Calcium. 47(5). 425–432. 116 indexed citations
18.
You, Changxuan, et al.. (2009). Comparison of AAV/IL-7 autocrine (T cell) versus paracrine (DC) gene delivery for enhancing CTL stimulation and function. Cancer Immunology Immunotherapy. 59(5). 779–787. 6 indexed citations
19.
Mahadevan, Mahendran, Yong Liu, Changxuan You, et al.. (2007). Generation of robust cytotoxic T lymphocytes against prostate specific antigen by transduction of dendritic cells using protein and recombinant adeno-associated virus. Cancer Immunology Immunotherapy. 56(10). 1615–1624. 23 indexed citations
20.
Zhou, Wenbo, Changxuan You, Hong Zheng, et al.. (2005). An autoimmune domain-reduced HCV core gene remains effective in stimulating anti-core cytotoxic T lymphocyte activity. Vaccine. 24(10). 1615–1624. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kalpit Shah Breakdown of academic impact, for papers by Jagmohan Hooda Breakdown of academic impact, for papers by Roseline Guibon Breakdown of academic impact, for papers by Basma Guarmit Breakdown of academic impact, for papers by Shangyi Fu Breakdown of academic impact, for papers by Thomas Strub Breakdown of academic impact, for papers by Christopher J. Winters Breakdown of academic impact, for papers by Kenichi Iwai Breakdown of academic impact, for papers by Shahzad Bhatti Breakdown of academic impact, for papers by Aixia Ren
Rankless by CCL
2026